Etiology and pathogenesis of late-onset Alzheimer's disease (Q38178837)

30 August 2017

title

Etiology and pathogenesis of late-onset Alzheimer's disease (English)

1 reference

30 August 2017

0 references

0 references

Brian J Balin

1

1 reference

30 August 2017

Alan P Hudson

series ordinal

2

1 reference

30 August 2017

publication date

1 March 2014

1 reference

Current Allergy and Asthma Reports

30 August 2017

published in

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

417

1 reference

Alzheimer's disease clinical and research update for health care practitioners

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

A presenilin 1 mutation in the first case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Genetic dissection of Alzheimer disease, a heterogeneous disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

New frontiers in Alzheimer's disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The clinical epidemiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

A familial Alzheimer's disease locus on chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Alzheimer culprits: cellular crossroads and interplay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The amyloid precursor protein: a biochemical enigma in brain development, function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The multifactorial nature of Alzheimer's disease for developing potential therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Recent advance in immunotherapies for Alzheimer disease: with special reference to DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The amyloid hypothesis: let sleeping dogmas lie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

How do heart disease and stroke become risk factors for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Impaired insulin signaling and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E alleles as risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Cognitive change and the APOE epsilon 4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Alzheimer's disease: the cholesterol connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Inflammatory risk factors and pathologies associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

The genetics of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Genome-wide association study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Air pollution, oxidative stress, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Chlamydia pneumoniae infection of brain cells: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Chlamydia pneumoniae: modern insights into an ancient pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathobiology and course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Emerging roles of pathogens in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

A new story about an old guy: is Alzheimer's disease infectious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Olfaction in patients with mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Dysregulated microRNAs in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

MicroRNAs and deregulated gene expression networks in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Update on Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Intranasal delivery to the central nervous system: mechanisms and experimental considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Nanotechnologies: a strategy to overcome blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Lipid-based nanocarriers for CNS-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Immune response to nanomaterials: implications for medicine and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0417-1

Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms

21 January 2018

1 reference

12 December 2020

The interaction of amyloid-beta with ApoE.

1 reference

12 December 2020

Alzheimer's disease--a spirochetosis?

1 reference

12 December 2020

Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

1 reference

12 December 2020

Ibuprofen inhibits the synaptic failure induced by the amyloid-β peptide in hippocampal neurons.

1 reference

12 December 2020

Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients

1 reference

12 December 2020

Aluminum neurotoxicity--potential role in the pathogenesis of neurofibrillary tangle formation.

1 reference

12 December 2020

Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain

1 reference

12 December 2020

Inflammatory process in Alzheimer's Disease

1 reference

12 December 2020

Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways

1 reference

12 December 2020

Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures.

1 reference

12 December 2020

Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons

1 reference

12 December 2020

Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms

1 reference

12 December 2020

Apolipoprotein E gene and Alzheimer's disease: is tau the link?

1 reference

12 December 2020

Aluminum and Alzheimer's disease, a personal perspective after 25 years.

1 reference

12 December 2020

Aluminum involvement in the progression of Alzheimer's disease.

1 reference

12 December 2020

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

1 reference

12 December 2020

The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease

1 reference

12 December 2020

Alzheimer's disease and immunotherapy

1 reference

12 December 2020

A brief olfactory test for Alzheimer's disease

1 reference

12 December 2020

Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

1 reference

12 December 2020

Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease

1 reference

12 December 2020

From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia

1 reference

12 December 2020

Herpes simplex virus type 1 in Alzheimer's disease: the enemy within

1 reference

12 December 2020

10.1007/S11882-013-0417-1

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1007459932

0 references

1 reference